Subscribe To
Why are biophytis shares trading higher during premarket trading?
Biophytis SA BPTS has received approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized pa...
February 3, 2022, 9:03 am
Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook
Hologic Inc HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...
February 3, 2022, 8:33 am
Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook
Hologic Inc HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...
February 3, 2022, 8:33 am
Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook
Hologic Inc HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...
February 3, 2022, 8:33 am
Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. ...
February 3, 2022, 7:47 am
Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. ...
February 3, 2022, 7:47 am
Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook
Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. ...
February 3, 2022, 7:47 am
Align technology's q4 clear aligner revenues fall sequentially, margins compress
Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. ...
February 3, 2022, 7:42 am
Align technology's q4 clear aligner revenues fall sequentially, margins compress
Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. ...
February 3, 2022, 7:42 am
Align technology's q4 clear aligner revenues fall sequentially, margins compress
Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. ...
February 3, 2022, 7:42 am
Roche expects slower fy22 sales growth on lower demand for covid-19 tests
Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. ...
February 3, 2022, 7:37 am
Roche expects slower fy22 sales growth on lower demand for covid-19 tests
Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. ...
February 3, 2022, 7:37 am
Roche expects slower fy22 sales growth on lower demand for covid-19 tests
Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. ...
February 3, 2022, 7:37 am
Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales
Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion. t...
February 3, 2022, 7:33 am
Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales
Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion. t...
February 3, 2022, 7:33 am
Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales
Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion. t...
February 3, 2022, 7:33 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. ...
February 3, 2022, 5:50 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. ...
February 3, 2022, 5:50 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. ...
February 3, 2022, 5:50 am
Analysts bump up ups price target post q4 results
Analysts updated the price target for United Parcel Service, Inc UPS after Q4 results. thousands o...
February 2, 2022, 3:18 pm